BioSpace News Archive

Indus Holdings, Inc. (“Indus”) (CSE:INDS; OTCQX: INDXF), a leading, vertically-integrated cannabis company, will release its financial results for the first quarter 2020 (ended March 31, 2020) after the market closes on Thursday, May 28.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today provided an update on U.S. Companion Animal Market Trends through Friday, May 22nd.

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, today announces the presentation of results from a post hoc pooled analysis assessing the impact of baseline dyskinesia (pre-existing dyskinesia before istradefylline treatment) on the safety and efficacy of NOURIANZ® (istradefylline) in patients with Parkinson’s disease (PD) experiencing “OFF” episodes or “OFF” time.

GC376 was safe and effective in 4 animal models of coronaviral infections. Strong antiviral activity against SARS-CoV-2 and immediate manufacturing capabilities make protease inhibitor GC376 a potential candidate for the treatment of COVID-19 in humans.

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, announced today that William “BJ” Jones, Chief Commercial Officer, Migraine and Common Disease at Biohaven Pharmaceuticals, has joined LUNGevity’s Board of Directors.

Headspring has partnered with Plasma Protein Therapeutics Association (PPTA) to develop a single, responsive web application that will enhance the collection and transmission of lifesaving plasma used to treat patients with rare and chronic diseases.

DLA Piper represented Seattle-based Stratos Genomics, an early-stage sequencing technology company, in its acquisition by biotechnology company Roche.

Leading global experts contributed to the report, which offers clear guidance and recommendations on ethics and governance as digital technologies are developed to fight the pandemic

Prevail Therapeutics Inc., a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, announced that Asa Abeliovich, M.D., Ph.D., Founder and Chief Executive Officer, will present a company overview at the upcoming Jefferies Virtual Global Healthcare Conference on Tuesday, June 2, 2020 at 3:30 p.m. ET.

Neovasc Inc. announced an offering of convertible notes and warrants to Strul Medical Group for gross proceeds of up to US$5.0 Million;